相关实验视频

Updated: Jul 20, 2025

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

在MNRR1激活剂尼塔佐化物中,它在小鼠中取消了脂聚糖诱导的早产

Neeraja Purandare¹, Nardhy Gomez-Lopez², Marcia Arenas-Hernandez³

¹Pregnancy Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS), Bethesda, MD 20892, USA; Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, 48201, USA.

|August 6, 2023

概括

尼塔佐胺激活了MNRR1,这是细胞功能的关键调节者. 这种药物有效地防止过早分娩在鼠标模型的胚胎内炎症,提供一个潜在的治疗策略.

科学领域:

产科和妇科产科和妇科
细胞生物学细胞生物学
药理学药理学是指药理学的学科.

背景情况:

腹膜内炎症是早产的主要原因,导致新生儿显著的发病率和死亡率.
线粒体核逆行,调节剂1 (MNRR1) 水平在炎症期间下降,影响细胞功能.
以前的研究表明,增加MNRR1水平可以抵消炎症反应.

研究的目的:

调查尼塔佐化物作为早产的潜在治疗剂.
为了确定尼塔佐胺是否激活MNRR1并减轻炎症诱导的早产.

主要方法:

采用了一种成熟的小鼠模型,通过注射内脂多糖 (LPS) 诱导的早产.
评估了尼塔佐胺对MNRR1激活和早产率的影响.

主要成果:

尼塔佐化物被确定为MNRR1.1的激活剂.
在LPS诱导的小鼠模型中,给予尼塔佐化物取消了早产.
药物的作用与其调节MNRR1活性的能力有关.

结论:

在实验模型中,Nitazoxanide在预防早产方面表现出有效性.
用尼塔佐胺针对MNRR1是一个有前途的治疗途径,用于管理胚胎内炎症和预防早产.

关键词:

CHCHD2是指CHCHD2的第二个部分.这是决定性的决定.胚胎内感染胚胎内感染腹膜内炎症是什么意思尼塔佐克桑化物 (Alinia) 的使用过早生育过早生育过早生育的劳动是不必要的.

更多相关视频

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C

Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C

Published on: March 25, 2016

相关概念视频